Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SMS pseudogene 1 (SMSP1) is a genomic sequence related to the Spermine synthase (SMS) gene but has been rendered non-coding by mutations or regulatory loss. Pseudogenes such as SMSP1 do not produce a functional protein and are typically regarded as non-functional genetic elements. However, some pseudogenes can exert regulatory effects on their parent genes—such as altering mRNA stability, acting as competing endogenous RNAs, or contributing to genetic diversity through recombinational events. To date, there is no evidence that SMSP1 has a direct role in disease, functions as a therapeutic target, or is associated with recognized biomarkers or interacting drugs.
None applicable for drugs; pseudogenes are not protein targets but may impact disease indirectly via gene regulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SMS pseudogene 1 (SMSP1).